|
ABOUT COMPANY
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, is dedicated to the discovery and development of new therapies to treat liver and metabolic diseases, retinal diseases, and cancer. The company is headquartered in South San Francisco, California.
|
EARNINGS
Gross Profit (TTM): -76604000
Market Capitalization: 1445389000
Operating Margin (TTM): -1.58
PE Ratio: None
PEG Ratio: 0
Profit Margin: -1.579
Revenue Per Share (TTM): 1.023
Revenue (TTM): 76690000
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: -0.209
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -1.615
Dividend Date: None
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: -6796000
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|